{"id":"https://openalex.org/W2000640630","doi":"https://doi.org/10.1371/journal.pone.0084409","title":"Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents","display_name":"Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents","publication_year":2013,"publication_date":"2013-12-26","ids":{"openalex":"https://openalex.org/W2000640630","doi":"https://doi.org/10.1371/journal.pone.0084409","mag":"2000640630","pmid":"https://pubmed.ncbi.nlm.nih.gov/24386374","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3873466"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0084409","doi":"https://doi.org/10.1371/journal.pone.0084409","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0084409","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0084409&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0084409&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111080803","display_name":"Leslie W. Tari","orcid":"https://orcid.org/0009-0008-8621-3299","observed_orcids":["https://orcid.org/0009-0008-8621-3299"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Leslie W. Tari","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100452145","display_name":"Xiaoming Li","orcid":"https://orcid.org/0000-0003-1795-0371","observed_orcids":["https://orcid.org/0000-0003-1795-0371","https://orcid.org/0009-0005-9675-1144","https://orcid.org/0009-0008-6865-4867","https://orcid.org/0000-0002-0431-8564"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoming Li","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027409273","display_name":"Michael Trzoss","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Trzoss","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078707644","display_name":"Daniel C. Bensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel C. Bensen","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101544000","display_name":"Zhiyong Chen","orcid":"https://orcid.org/0000-0001-5032-8280","observed_orcids":["https://orcid.org/0000-0001-5032-8280"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhiyong Chen","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039881624","display_name":"Thanh Lam","orcid":"https://orcid.org/0000-0002-4749-6096","observed_orcids":["https://orcid.org/0000-0002-4749-6096"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thanh Lam","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025031597","display_name":"Junhu Zhang","orcid":"https://orcid.org/0000-0001-9100-6608","observed_orcids":["https://orcid.org/0000-0001-9100-6608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Junhu Zhang","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054819415","display_name":"Suk Joong Lee","orcid":"https://orcid.org/0000-0003-1387-5714","observed_orcids":["https://orcid.org/0000-0003-1387-5714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suk Joong Lee","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049077059","display_name":"Grayson Hough","orcid":"https://orcid.org/0009-0003-4960-2811","observed_orcids":["https://orcid.org/0009-0003-4960-2811"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grayson Hough","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078641399","display_name":"Doug Phillipson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Doug Phillipson","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084334848","display_name":"Suzanne Akers-Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne Akers-Rodriguez","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111672590","display_name":"Mark L. Cunningham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark L. Cunningham","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058399753","display_name":"Bryan P. Kwan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryan P. Kwan","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024762909","display_name":"Kirk J. Nelson","orcid":"https://orcid.org/0000-0003-1160-5251","observed_orcids":["https://orcid.org/0000-0003-1160-5251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kirk J. Nelson","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077275234","display_name":"Amanda Castellano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Castellano","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010350552","display_name":"Jeffrey B. Locke","orcid":"https://orcid.org/0000-0001-8145-0828","observed_orcids":["https://orcid.org/0000-0001-8145-0828"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeff B. Locke","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026266602","display_name":"Vickie Brown\u2010Driver","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vickie Brown-Driver","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102092718","display_name":"Timothy M. Murphy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timothy M. Murphy","raw_affiliation_strings":["ViviSource Laboratories, Waltham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ViviSource Laboratories, Waltham","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090249918","display_name":"Voon S. Ong","orcid":"https://orcid.org/0000-0001-8676-6717","observed_orcids":["https://orcid.org/0000-0001-8676-6717"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Voon S. Ong","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110265679","display_name":"Chris M. Pillar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris M. Pillar","raw_affiliation_strings":["Micromyx LLC, Kalamazoo, Michigan, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Micromyx LLC, Kalamazoo, Michigan, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043711375","display_name":"Dean L. Shinabarger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dean L. Shinabarger","raw_affiliation_strings":["Micromyx LLC, Kalamazoo, Michigan, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Micromyx LLC, Kalamazoo, Michigan, United States of America","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055041718","display_name":"Jay C. Nix","orcid":"https://orcid.org/0000-0002-4041-4975","observed_orcids":["https://orcid.org/0000-0002-4041-4975"]},"institutions":[{"id":"https://openalex.org/I4387152530","display_name":"Advanced Light Source","ror":"https://ror.org/00319zh75","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I148283060","https://openalex.org/I39565521","https://openalex.org/I4387152530"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jay Nix","raw_affiliation_strings":["Advanced Light Source, Beamline 4.2.2, Berkeley, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Advanced Light Source, Beamline 4.2.2, Berkeley, California, United States of America","institution_ids":["https://openalex.org/I4387152530"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020056606","display_name":"Felice C. Lightstone","orcid":"https://orcid.org/0000-0003-1465-426X","observed_orcids":["https://orcid.org/0000-0003-1465-426X"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Felice C. Lightstone","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112914666","display_name":"Sergio Wong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergio E. Wong","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109386889","display_name":"Toan B. Nguyen","orcid":"https://orcid.org/0000-0002-3216-6617","observed_orcids":["https://orcid.org/0000-0002-3216-6617"]},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Toan B. Nguyen","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Physical and Life Sciences Directorate, Livermore, California, United States of America","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086601088","display_name":"Karen Joy Shaw","orcid":"https://orcid.org/0000-0003-3060-1328","observed_orcids":["https://orcid.org/0000-0003-3060-1328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen J. Shaw","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"John Finn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John Finn","raw_affiliation_strings":["Trius Therapeutics, San Diego, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Trius Therapeutics, San Diego, California, United States of America","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111080803"],"corresponding_institution_ids":[],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":4.2689,"has_fulltext":true,"cited_by_count":105,"citation_normalized_percentile":{"value":0.95746431,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"8","issue":"12","first_page":"e84409","last_page":"e84409"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9692000150680542,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.006500000134110451,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dna-gyrase","display_name":"DNA gyrase","score":0.8209999799728394},{"id":"https://openalex.org/keywords/topoisomerase-iv","display_name":"topoisomerase IV","score":0.9929999709129333},{"id":"https://openalex.org/keywords/type-iia-topoisomerase","display_name":"type IIA topoisomerase","score":0.871999979019165},{"id":"https://openalex.org/keywords/structure-based-drug-design","display_name":"structure-based drug design","score":0.7609999775886536},{"id":"https://openalex.org/keywords/fluoroquinolone-resistance","display_name":"fluoroquinolone resistance","score":0.8960000276565552},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.9480000138282776},{"id":"https://openalex.org/keywords/gram-negative-bacteria","display_name":"Gram-negative bacteria","score":0.6899999976158142},{"id":"https://openalex.org/keywords/gram-positive-bacteria","display_name":"Gram-positive bacteria","score":0.8989999890327454},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.4880000054836273},{"id":"https://openalex.org/keywords/antibiotic-discovery","display_name":"antibiotic discovery","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C167125095","wikidata":"https://www.wikidata.org/wiki/Q70551687","display_name":"DNA gyrase","level":4,"score":0.8906259536743164},{"id":"https://openalex.org/C2777112418","wikidata":"https://www.wikidata.org/wiki/Q7824976","display_name":"Topoisomerase IV","level":5,"score":0.7623765468597412},{"id":"https://openalex.org/C147897179","wikidata":"https://www.wikidata.org/wiki/Q407828","display_name":"Topoisomerase","level":3,"score":0.5659564733505249},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49031999707221985},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.4824393689632416},{"id":"https://openalex.org/C2780104969","wikidata":"https://www.wikidata.org/wiki/Q4774530","display_name":"Antibacterial activity","level":3,"score":0.46237868070602417},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.38123488426208496},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35932421684265137},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.24117332696914673},{"id":"https://openalex.org/C547475151","wikidata":"https://www.wikidata.org/wiki/Q25419","display_name":"Escherichia coli","level":3,"score":0.23388728499412537},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2267177700996399},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1557198464870453},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15377873182296753},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.07350438833236694}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001419","descriptor_name":"Bacteria","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011487","descriptor_name":"Protein Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D024881","descriptor_name":"Drug Resistance, Bacterial","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D027081","descriptor_name":"DNA Gyrase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D027081","descriptor_name":"DNA Gyrase","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D027101","descriptor_name":"DNA Topoisomerase IV","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D027101","descriptor_name":"DNA Topoisomerase IV","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D059005","descriptor_name":"Topoisomerase II Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":8,"locations":[{"id":"doi:10.1371/journal.pone.0084409","doi":"https://doi.org/10.1371/journal.pone.0084409","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0084409","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0084409&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2865937","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3873466","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3873466","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3873466","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:24386374","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24386374","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.791.7540","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.791.7540","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/63/f4/pone.0084409.PMC3873466.pdf","raw_type":"text"},{"id":"pmh:oai:doaj.org/article:61b9ed4eb647499192d901bd0163432e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/61b9ed4eb647499192d901bd0163432e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 8, Iss 12, p e84409 (2013)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/887250","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/_Tricyclic_GyrB_ParE_TriBE_Inhibitors_A_New_Class_of_Broad_Spectrum_Dual_Targeting_Antibacterial_Agents_/887250","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:osti.gov:1237527","doi":null,"is_oa":false,"landing_page_url":"https://www.osti.gov/biblio/1237527","pdf_url":null,"source":{"id":"https://openalex.org/S4306402487","display_name":"OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I139351228","host_organization_name":"Office of Scientific and Technical Information","host_organization_lineage":["https://openalex.org/I139351228"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0084409","doi":"https://doi.org/10.1371/journal.pone.0084409","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0084409","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0084409&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1356433355","display_name":null,"funder_award_id":"DE\u2010AC5207NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G14554683","display_name":null,"funder_award_id":"DEAC5207NA27344","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G1716777315","display_name":null,"funder_award_id":"DE-AC52-07NA27344","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G2145270357","display_name":null,"funder_award_id":"AC52\u201007NA27344","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G3551755275","display_name":null,"funder_award_id":"HHSN272200800042C","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3669113783","display_name":null,"funder_award_id":"07NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G4343739756","display_name":null,"funder_award_id":"Contract DE-AC52-07NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G4842577516","display_name":null,"funder_award_id":"272200800042C","funder_id":"https://openalex.org/F4320332505","funder_display_name":"U.S. Public Health Service"},{"id":"https://openalex.org/G6484198760","display_name":null,"funder_award_id":"LLNL-JRNL-565619","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G69709960","display_name":null,"funder_award_id":"Contract DE-AC52-07NA27344","funder_id":"https://openalex.org/F4320306084","funder_display_name":"U.S. Department of Energy"},{"id":"https://openalex.org/G895790057","display_name":null,"funder_award_id":"DE-AC52","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"},{"id":"https://openalex.org/G991281326","display_name":null,"funder_award_id":"AC52-07NA27344","funder_id":"https://openalex.org/F4320338286","funder_display_name":"Lawrence Livermore National Laboratory"}],"funders":[{"id":"https://openalex.org/F4320306084","display_name":"U.S. Department of Energy","ror":"https://ror.org/01bj3aw27"},{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320338286","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000640630.pdf","grobid_xml":"https://content.openalex.org/works/W2000640630.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1933307438","https://openalex.org/W1970798262","https://openalex.org/W1974672939","https://openalex.org/W1977078454","https://openalex.org/W1978681980","https://openalex.org/W1979474715","https://openalex.org/W1980082881","https://openalex.org/W1980482232","https://openalex.org/W1985588649","https://openalex.org/W1986191025","https://openalex.org/W2001641653","https://openalex.org/W2010463671","https://openalex.org/W2014989916","https://openalex.org/W2037001581","https://openalex.org/W2047245810","https://openalex.org/W2049245087","https://openalex.org/W2069270290","https://openalex.org/W2071325808","https://openalex.org/W2074986801","https://openalex.org/W2077451485","https://openalex.org/W2093742668","https://openalex.org/W2099617977","https://openalex.org/W2105668062","https://openalex.org/W2116947993","https://openalex.org/W2119567467","https://openalex.org/W2122273366","https://openalex.org/W2124026197","https://openalex.org/W2124525553","https://openalex.org/W2125634299","https://openalex.org/W2132175878","https://openalex.org/W2138848871","https://openalex.org/W2139516496","https://openalex.org/W2159211495","https://openalex.org/W2163341755","https://openalex.org/W2166761684","https://openalex.org/W2166765429","https://openalex.org/W2793938485","https://openalex.org/W7073696094"],"related_works":["https://openalex.org/W2184581544","https://openalex.org/W955180060","https://openalex.org/W2069270290","https://openalex.org/W2913043631","https://openalex.org/W2804617846","https://openalex.org/W4211105863","https://openalex.org/W2071325808","https://openalex.org/W2403261646","https://openalex.org/W1978681980","https://openalex.org/W2516294671"],"abstract_inverted_index":{"Increasing":[0],"resistance":[1,64],"to":[2,65,130],"every":[3],"major":[4],"class":[5],"of":[6,11,14,25,80,104,122,150,164,193,211],"antibiotics":[7],"and":[8,39,108,147,186,208,217,235],"a":[9,22,175,190],"dearth":[10],"novel":[12,176],"classes":[13,90],"antibacterial":[15,44,124,159,204],"agents":[16,125],"in":[17,71,144,233,237],"development":[18,121],"pipelines":[19],"has":[20],"created":[21,174],"dwindling":[23],"reservoir":[24],"treatment":[26],"options":[27],"for":[28,87,119],"serious":[29],"bacterial":[30,33],"infections.":[31],"The":[32,99],"type":[34],"IIA":[35],"topoisomerases,":[36],"DNA":[37,105],"gyrase":[38,106],"topoisomerase":[40,97,109],"IV,":[41],"are":[42,230],"validated":[43],"drug":[45,50,169],"targets":[46],"with":[47,126,157,181,226],"multiple":[48],"prospective":[49],"binding":[51],"sites,":[52],"including":[53,214],"the":[54,59,72,78,85,96,120,145,162],"catalytic":[55],"site":[56],"targeted":[57],"by":[58,69],"fluoroquinolone":[60,215],"antibiotics.":[61],"However,":[62,129],"growing":[63],"fluoroquinolones,":[66],"frequently":[67],"mediated":[68],"mutations":[70],"drug-binding":[73],"site,":[74],"is":[75],"increasingly":[76],"limiting":[77],"utility":[79],"this":[81,199],"antibiotic":[82],"class,":[83],"prompting":[84],"search":[86],"other":[88],"inhibitor":[89,179],"that":[91],"target":[92],"different":[93],"sites":[94,141],"on":[95],"complexes.":[98],"highly":[100],"conserved":[101],"ATP-binding":[102],"subunits":[103],"(GyrB)":[107],"IV":[110],"(ParE)":[111],"have":[112,142,153,173,223],"long":[113],"been":[114,155,224],"recognized":[115],"as":[116],"excellent":[117],"candidates":[118],"dual-targeting":[123,177],"broad-spectrum":[127,158,203],"potential.":[128],"date,":[131],"no":[132,148],"natural":[133],"product":[134],"or":[135],"small":[136],"molecule":[137],"inhibitors":[138,149],"targeting":[139],"these":[140,151],"succeeded":[143],"clinic,":[146],"enzymes":[152,188],"yet":[154],"reported":[156],"activity":[160,205],"encompassing":[161],"majority":[163],"Gram-negative":[165,209,238],"pathogens.":[166,196],"Using":[167],"structure-based":[168],"design":[170],"(SBDD),":[171],"we":[172],"pyrimidoindole":[178],"series":[180,200],"exquisite":[182],"potency":[183],"against":[184,206],"GyrB":[185],"ParE":[187],"from":[189,198],"broad":[191],"range":[192],"clinically":[194],"important":[195],"Inhibitors":[197],"demonstrate":[201],"potent,":[202],"Gram-positive":[207],"pathogens":[210],"clinical":[212,227],"importance,":[213],"resistant":[216,219],"multidrug":[218],"strains.":[220],"Lead":[221],"compounds":[222],"discovered":[225],"potential;":[228],"they":[229],"well":[231],"tolerated":[232],"animals,":[234],"efficacious":[236],"infection":[239],"models.":[240]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":11}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}